The Chronic Kidney Disease Market is expanding as the global burden of kidney disorders continues to rise alongside diabetes, hypertension, and aging populations. According to Market Research Future, the market was valued at USD 40.53 billion in 2024 and is projected to reach USD 75.22 billion by 2035, registering a 5.78% CAGR from 2025 to 2035.
Growing awareness of early kidney disease detection is increasing demand for diagnostic testing and ongoing disease monitoring. Healthcare providers are also adopting more advanced treatment approaches as patients require long-term management of progressive kidney dysfunction.
Blood tests represent the largest diagnosis segment, accounting for about 42% of the market in 2024, supported by widespread use of serum creatinine and eGFR measurements. Dialysis leads the treatment segment with approximately 48% share, while kidney transplantation is emerging as the fastest-growing treatment category.
North America held more than 45% of the global market in 2024, supported by advanced healthcare infrastructure and substantial treatment demand. Europe represented about 30%, while Asia-Pacific offers attractive growth opportunities because of rising diabetes and cardiovascular disease prevalence and expanding healthcare investment.
Future opportunities are likely to center on AI-assisted diagnosis, personalized treatment, telehealth, and home dialysis. As healthcare systems focus increasingly on earlier intervention and patient-centered care, innovations that improve monitoring and treatment convenience could significantly influence the long-term CKD market.
Gain a competitive edge with insightful market reports:
Japan Smart Healthcare Market Outlook
France Digital Healthcare Market Analysis
Spain Radiopharmaceuticals Market Distribution
